Answer
SomaKit TOC (edotreotide) should be used during pregnancy only for essential investigations when the likely benefit far exceeds the risk to the mother and foetus, because radionuclide procedures expose the foetus to radiation and no pregnancy-use data are available.
Sources for this answer
- SomaKit TOC 40 micrograms kit for radiopharmaceutical preparationNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked